These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16134819)

  • 1. Leukoplakia of oral mucosa: pathogenesis and possible correction with phytoadaptogen.
    Bocharova OA; Pozharitskaya MM; Chekalina TL; Lyzhenkova MA; Karpova RV; Mezentseva MV; Ershov FI
    Bull Exp Biol Med; 2004 Dec; 138(6):578-83. PubMed ID: 16134819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of beta-carotene on immune functions.
    Prabhala RH; Braune LM; Garewal HS; Watson RR
    Ann N Y Acad Sci; 1993 Dec; 691():262-3. PubMed ID: 7907461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improving the efficiency of combined therapy of patients with leukoplakia of the buccal mucosa using Phytomix-40 combined plant preparation].
    Chekalina TL; Pozharitskaia MM; Bocharova OA
    Stomatologiia (Mosk); 2004; 83(5):24-30. PubMed ID: 15477836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive therapy of andrographolide in vocal fold leukoplakia.
    Xu J; Xue T; Bao Y; Wang DH; Ma BL; Yin CY; Yang GH; Ren G; Lan LJ; Wang JQ; Zhang XL; Zhao YQ
    Am J Otolaryngol; 2014; 35(2):77-84. PubMed ID: 24444776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hyperplastic candidiasis--candidal leukoplakia.
    Cawson RA; Lehner T
    Br J Dermatol; 1968 Jan; 80(1):9-16. PubMed ID: 5638257
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial.
    Armstrong WB; Kennedy AR; Wan XS; Taylor TH; Nguyen QA; Jensen J; Thompson W; Lagerberg W; Meyskens FL
    Clin Cancer Res; 2000 Dec; 6(12):4684-91. PubMed ID: 11156220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion.
    Ma N; Tagawa T; Hiraku Y; Murata M; Ding X; Kawanishi S
    Nitric Oxide; 2006 Mar; 14(2):137-43. PubMed ID: 16290060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryogun cryotherapy for oral leukoplakia.
    Lin HP; Chen HM; Cheng SJ; Yu CH; Chiang CP
    Head Neck; 2012 Sep; 34(9):1306-11. PubMed ID: 22084001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathology of oral leukoplakia.
    Lehner T
    Br J Cancer; 1970 Sep; 24(3):442-6. PubMed ID: 4319938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of mesenchymal stem cells derived from oral leukoplakia.
    Zhang Z; Song J; Han Y; Mu D; Su S; Ji X; Liu H
    Int J Clin Exp Pathol; 2015; 8(9):10026-37. PubMed ID: 26617710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytoadaptogen correction of clinical and immunobiological parameters in patients with benign prostatic hyperplasia.
    Bocharova OA; Matveev VB; Karpova RV; Aksyonov AA; Gorozhanskaya EG; Chebotaryov FN; Katosova LD; Platonova VI; Bochkov NP
    Bull Exp Biol Med; 2006 May; 141(5):616-9. PubMed ID: 17181067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytoadaptogen for preventive oncology: immunobiological criteria of composition.
    Bocharova OA; Lyzhenkova MA; Mezentseva MV; Semernina VV; Knyazhev VA
    Bull Exp Biol Med; 2003 Dec; 136(6):591-4. PubMed ID: 15500081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between vocal fold leukoplakia and gastropharyngeal reflux:analysis of 15 cases].
    Ni X; Wang XY; Zhang YH; Wang XY
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(19):1323-6. PubMed ID: 18956701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of oral leukoplakia to beta-carotene.
    Garewal HS; Meyskens FL; Killen D; Reeves D; Kiersch TA; Elletson H; Strosberg A; King D; Steinbronn K
    J Clin Oncol; 1990 Oct; 8(10):1715-20. PubMed ID: 2213107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of vitamin A acid in diseases of the mouth mucosa: lichen ruber planus, leukoplakias and geographic tongue].
    Günther S
    Z Hautkr; 1975 Jan; 50(1):41-6. PubMed ID: 1216954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Scanning electron microscopy of oral leukoplakia].
    Bánóczy J; Lapis K; Albrecht M
    Morphol Igazsagugyi Orv Sz; 1979 Oct; 19(4):258-62. PubMed ID: 530283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [State of the nervous system in kraurosis and leukoplakia of the vulva].
    Shtemberg MI
    Akush Ginekol (Mosk); 1973 Dec; 49(12):55-7. PubMed ID: 4775374
    [No Abstract]   [Full Text] [Related]  

  • 19. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
    Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
    APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukoplakia of the vulva locally treated by 13-cis-retinoic acid.
    Markowska J; Janik P; Wiese E; Ostrowski J
    Neoplasma; 1987; 34(1):33-6. PubMed ID: 3470615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.